Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study.
Saved in:
| Title: | Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study. |
|---|---|
| Authors: | Kamperman RG; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands. Electronic address: r.kamperman@amsterdamumc.nl., van Leeuwen EM; Department of Experimental Immunology, Amsterdam Institute for Infection & Immunity, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands., Willems M; Department of Neurology, Diakonessenhuis Medical Centre, Utrecht, the Netherlands., van der Kooi AJ; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands., Gelderman KA; Sanquin Diagnostic Services, Amsterdam, the Netherlands., Hamann D; Central Diagnostic Laboratory/Centre of Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht, the Netherlands., van Lochem EG; Rijnstate Hospital, Department of Microbiology and Immunology, Arnhem, the Netherlands., Meek B; St. Antonius Hospital, Department of Medical Microbiology and Immunology, Nieuwegein, the Netherlands., van der Molen RG; Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, the Netherlands., Platteel AC; Rijnstate Hospital, Department of Microbiology and Immunology, Arnhem, the Netherlands., Otten HG; Central Diagnostic Laboratory/Centre of Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht, the Netherlands., Schreurs MW; Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Microvida, Tilburg, the Netherlands., Raaphorst J; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands. |
| Corporate Authors: | Dutch Myositis Network |
| Source: | Journal of autoimmunity [J Autoimmun] 2023 Sep; Vol. 139, pp. 103081. Date of Electronic Publication: 2023 Jun 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academic Press Country of Publication: England NLM ID: 8812164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9157 (Electronic) Linking ISSN: 08968411 NLM ISO Abbreviation: J Autoimmun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37393780 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kamperman+RG%22">Kamperman RG</searchLink>; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands. Electronic address: r.kamperman@amsterdamumc.nl.<br /><searchLink fieldCode="AU" term="%22van+Leeuwen+EM%22">van Leeuwen EM</searchLink>; Department of Experimental Immunology, Amsterdam Institute for Infection & Immunity, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Willems+M%22">Willems M</searchLink>; Department of Neurology, Diakonessenhuis Medical Centre, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Kooi+AJ%22">van der Kooi AJ</searchLink>; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Gelderman+KA%22">Gelderman KA</searchLink>; Sanquin Diagnostic Services, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hamann+D%22">Hamann D</searchLink>; Central Diagnostic Laboratory/Centre of Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Lochem+EG%22">van Lochem EG</searchLink>; Rijnstate Hospital, Department of Microbiology and Immunology, Arnhem, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Meek+B%22">Meek B</searchLink>; St. Antonius Hospital, Department of Medical Microbiology and Immunology, Nieuwegein, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Molen+RG%22">van der Molen RG</searchLink>; Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Platteel+AC%22">Platteel AC</searchLink>; Rijnstate Hospital, Department of Microbiology and Immunology, Arnhem, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Otten+HG%22">Otten HG</searchLink>; Central Diagnostic Laboratory/Centre of Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schreurs+MW%22">Schreurs MW</searchLink>; Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Microvida, Tilburg, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Raaphorst+J%22">Raaphorst J</searchLink>; Department of Neurology, Neuroscience Institute, Amsterdam University Medical Centre (AUMC), location AMC, the Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Dutch+Myositis+Network%22">Dutch Myositis Network</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228812164%22">Journal of autoimmunity</searchLink> [J Autoimmun] 2023 Sep; Vol. 139, pp. 103081. <i>Date of Electronic Publication: </i>2023 Jun 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8812164 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-9157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208968411%22">08968411 </searchLink><i>NLM ISO Abbreviation: </i>J Autoimmun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37393780 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jaut.2023.103081 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 103081 Titles: – TitleFull: Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kamperman RG – PersonEntity: Name: NameFull: van Leeuwen EM – PersonEntity: Name: NameFull: Willems M – PersonEntity: Name: NameFull: van der Kooi AJ – PersonEntity: Name: NameFull: Gelderman KA – PersonEntity: Name: NameFull: Hamann D – PersonEntity: Name: NameFull: van Lochem EG – PersonEntity: Name: NameFull: Meek B – PersonEntity: Name: NameFull: van der Molen RG – PersonEntity: Name: NameFull: Platteel AC – PersonEntity: Name: NameFull: Otten HG – PersonEntity: Name: NameFull: Schreurs MW – PersonEntity: Name: NameFull: Raaphorst J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1095-9157 Numbering: – Type: volume Value: 139 Titles: – TitleFull: Journal of autoimmunity Type: main |
| ResultId | 1 |